Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

HIV infection among men who have sex with men in Israel: a 35-year epidemiological and clinical overview, 1981-2015.

Chemtob D, Mor Z, Harel N, Averick N.

BMC Public Health. 2019 Jun 13;19(1):747. doi: 10.1186/s12889-019-7000-1. Review.

2.

Use of Geographically Weighted Poisson Regression to examine the effect of distance on Tuberculosis incidence: A case study in Nam Dinh, Vietnam.

Bui LV, Mor Z, Chemtob D, Ha ST, Levine H.

PLoS One. 2018 Nov 12;13(11):e0207068. doi: 10.1371/journal.pone.0207068. eCollection 2018.

3.

Identification and characterization of HIV positive Ethiopian elite controllers in both Africa and Israel.

Kiros YK, Elinav H, Gebreyesus A, Gebremeskel H, Azar J, Chemtob D, Abreha H, Elbirt D, Shahar E, Chowers M, Turner D, Grossman Z, Haile A, Sutton RE, Maayan SL, Wolday D.

HIV Med. 2019 Jan;20(1):33-37. doi: 10.1111/hiv.12680. Epub 2018 Oct 14.

4.

The risk of tuberculosis in cancer patients is greatest in lymphoma and myelodysplastic syndrome/myeloproliferative neoplasm: a large population-based cohort study.

Ganzel C, Silverman B, Chemtob D, Ben Shoham A, Wiener-Well Y.

Leuk Lymphoma. 2019 Mar;60(3):720-725. doi: 10.1080/10428194.2018.1499904. Epub 2018 Sep 6.

PMID:
30188229
5.

Evaluation of the virtues and pitfalls in an HIV screening algorithm based on two fourth generation assays - A step towards an improved national algorithm.

Avidor B, Chemtob D, Turner D, Zeldis I, Girshengorn S, Matus N, Achsanov S, Gielman S, Schweizer I, Baskin L, Schreiber L, Kra-Oz Z.

J Clin Virol. 2018 Sep;106:18-22. doi: 10.1016/j.jcv.2018.06.017. Epub 2018 Jul 9.

PMID:
30007138
6.

Cross-border outbreak of extensively drug-resistant tuberculosis linked to a university in Romania.

Popovici O, Monk P, Chemtob D, Chiotan D, Freidlin PJ, Groenheit R, Haanperä M, Homorodean D, Mansjö M, Robinson E, Rorman E, Smith G, Soini H, Van Der Werf MJ.

Epidemiol Infect. 2018 May;146(7):824-831. doi: 10.1017/S095026881800047X.

PMID:
29769160
7.

Diagnosis of HIV-1 infection: Performance of Xpert Qual and Geenius supplemental assays in fourth generation ELISA-reactive samples.

Rakovsky A, Gozlan Y, Bassal R, Wax M, Shirazi R, Bakhanashvili M, Kra-Oz Z, Radian-Sade S, Ben-Zvi H, Schreiber L, Wolf DG, Shemer-Avni Y, Chemtob D, Mendelson E, Mor O.

J Clin Virol. 2018 Apr;101:7-10. doi: 10.1016/j.jcv.2018.01.007. Epub 2018 Jan 17.

PMID:
29414189
8.

Causes of death and mortality trends of all individuals reported with HIV/AIDS in Israel, 1985-2010.

Mor Z, Sheffer R, Chemtob D.

J Public Health (Oxf). 2018 Mar 1;40(1):56-64. doi: 10.1093/pubmed/fdx039.

9.

A national strategic plan for reducing the burden of sexually transmitted infections in Israel by the year 2025.

Chemtob D, Gandacu D, Mor Z, Grotto I, Anis E, Rosenberg E.

Isr J Health Policy Res. 2017 Apr 19;6:23. doi: 10.1186/s13584-017-0141-8. eCollection 2017.

10.

Mother-to-child HIV transmissions in Israel, 1985-2011.

Mor Z, Sheffer R, Chemtob D.

Epidemiol Infect. 2017 Jul;145(9):1913-1921. doi: 10.1017/S0950268817000577. Epub 2017 Apr 4.

PMID:
28374653
11.

Structure and variation of CRISPR and CRISPR-flanking regions in deleted-direct repeat region Mycobacterium tuberculosis complex strains.

Freidlin PJ, Nissan I, Luria A, Goldblatt D, Schaffer L, Kaidar-Shwartz H, Chemtob D, Dveyrin Z, Head SR, Rorman E.

BMC Genomics. 2017 Feb 15;18(1):168. doi: 10.1186/s12864-017-3560-6.

12.

Should Men who have sex with Men be allowed to donate blood in Israel?

Ginsberg GM, Shinar E, Kopel E, Chemtob D.

Isr J Health Policy Res. 2016 Dec 13;5:60. doi: 10.1186/s13584-016-0123-2. eCollection 2016.

13.

Successful control of a large outbreak of HIV infection associated with injection of cathinone derivatives in Tel Aviv, Israel.

Katchman E, Ben-Ami R, Savyon M, Chemtob D, Avidor B, Wasserman A, Zeldis I, Girshengorn S, Amitai Z, Sheffer R, Turner D.

Clin Microbiol Infect. 2017 May;23(5):336.e5-336.e8. doi: 10.1016/j.cmi.2016.11.009. Epub 2016 Nov 20.

14.

Invasive pneumococcal disease (IPD) in HIV infected patients in Israel since the introduction of pneumococcal conjugated vaccines (PCV): Analysis of a nationwide surveillance study, 2009-2014.

Chowers M, Regev-Yochay G, Mor O, Cohen-Poradosu R, Riesenberg K, Zimhony O, Chemtob D, Stein M, Dagan R, Levy I.

Hum Vaccin Immunother. 2017 Jan 2;13(1):216-219. doi: 10.1080/21645515.2016.1229720.

15.

Erratum to: 'HIV prevalence in the Israeli tuberculosis cohort, 1999-2011'.

Mor Z, Lidji M, Chemtob D, Cedar N, Grotto I.

BMC Public Health. 2016 Apr 13;16:319. doi: 10.1186/s12889-016-2889-0. No abstract available.

16.

Mortality after anti-tuberculosis treatment completion: results of long-term follow-up.

Shuldiner J, Leventhal A, Chemtob D, Mor Z.

Int J Tuberc Lung Dis. 2016 Jan;20(1):43-8. doi: 10.5588/ijtld.14.0427.

PMID:
26688527
17.

Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe.

Hofstra LM, Sauvageot N, Albert J, Alexiev I, Garcia F, Struck D, Van de Vijver DAMC, Åsjö B, Beshkov D, Coughlan S, Descamps D, Griskevicius A, Hamouda O, Horban A, Van Kasteren M, Kolupajeva T, Kostrikis LG, Liitsola K, Linka M, Mor O, Nielsen C, Otelea D, Paraskevis D, Paredes R, Poljak M, Puchhammer-Stöckl E, Sönnerborg A, Staneková D, Stanojevic M, Van Laethem K, Zazzi M, Zidovec Lepej S, Boucher CAB, Schmit JC, Wensing AMJ; SPREAD Program, Puchhammer-Stockl E, Sarcletti M, Schmied B, Geit M, Balluch G, Vandamme AM, Vercauteren J, Derdelinckx I, Sasse A, Bogaert M, Ceunen H, De Roo A, De Wit S, Echahidi F, Fransen K, Goffard JC, Goubau P, Goudeseune E, Yombi JC, Lacor P, Liesnard C, Moutschen M, Pierard D, Rens R, Schrooten Y, Vaira D, Vandekerckhove LPR, Van den Heuvel A, Van Der Gucht B, Van Ranst M, Van Wijngaerden E, Vandercam B, Vekemans M, Verhofstede C, Clumeck N, Van Laethem K, Beshkov D, Alexiev I, Lepej SZ, Begovac J, Kostrikis L, Demetriades I, Kousiappa I, Demetriou V, Hezka J, Linka M, Maly M, Machala L, Nielsen C, Jørgensen LB, Gerstoft J, Mathiesen L, Pedersen C, Nielsen H, Laursen A, Kvinesdal B, Liitsola K, Ristola M, Suni J, Sutinen J, Descamps D, Assoumou L, Castor G, Grude M, Flandre P, Storto A, Hamouda O, Kücherer C, Berg T, Braun P, Poggensee G, Däumer M, Eberle J, Heiken H, Kaiser R, Knechten H, Korn K, Müller H, Neifer S, Schmidt B, Walter H, Gunsenheimer-Bartmeyer B, Harrer T, Paraskevis D, Hatzakis A, Zavitsanou A, Vassilakis A, Lazanas M, Chini M, Lioni A, Sakka V, Kourkounti S, Paparizos V, Antoniadou A, Papadopoulos A, Poulakou G, Katsarolis I, Protopapas K, Chryssos G, Drimis S, Gargalianos P, Xylomenos G, Lourida G, Psichogiou M, Daikos GL, Sipsas NV, Kontos A, Gamaletsou MN, Koratzanis G, Sambatakou H, Mariolis H, Skoutelis A, Papastamopoulos V, Georgiou O, Panagopoulos P, Maltezos E, Coughlan S, De Gascun C, Byrne C, Duffy M, Bergin C, Reidy D, Farrell G, Lambert J, O'Connor E, Rochford A, Low J, Coakely P, O'Dea S, Hall W, Mor O, Levi I, Chemtob D, Grossman Z, Zazzi M, de Luca A, Balotta C, Riva C, Mussini C, Caramma I, Capetti A, Colombo MC, Rossi C, Prati F, Tramuto F, Vitale F, Ciccozzi M, Angarano G, Rezza G, Kolupajeva T, Vasins O, Griskevicius A, Lipnickiene V, Schmit JC, Struck D, Sauvageot N, Hemmer R, Arendt V, Michaux C, Staub T, Sequin-Devaux C, Wensing AMJ, Boucher CAB, van de Vijver DAMC, van Kessel A, van Bentum PHM, Brinkman K, Connell BJ, van der Ende ME, Hoepelman IM, van Kasteren M, Kuipers M, Langebeek N, Richter C, Santegoets RMWJ, Schrijnders-Gudde L, Schuurman R, van de Ven BJM, Åsjö B, Kran AB, Ormaasen V, Aavitsland P, Horban A, Stanczak JJ, Stanczak GP, Firlag-Burkacka E, Wiercinska-Drapalo A, Jablonowska E, Maolepsza E, Leszczyszyn-Pynka M, Szata W, Camacho R, Palma C, Borges F, Paixão T, Duque V, Araújo F, Otelea D, Paraschiv S, Tudor AM, Cernat R, Chiriac C, Dumitrescu F, Prisecariu LJ, Stanojevic M, Jevtovic D, Salemovic D, Stanekova D, Habekova M, Chabadová Z, Drobkova T, Bukovinova P, Shunnar A, Truska P, Poljak M, Lunar M, Babic D, Tomazic J, Vidmar L, Vovko T, Karner P, Garcia F, Paredes R, Monge S, Moreno S, Del Amo J, Asensi V, Sirvent JL, de Mendoza C, Delgado R, Gutiérrez F, Berenguer J, Garcia-Bujalance S, Stella N, de Los Santos I, Blanco JR, Dalmau D, Rivero M, Segura F, Elías MJP, Alvarez M, Chueca N, Rodríguez-Martín C, Vidal C, Palomares JC, Viciana I, Viciana P, Cordoba J, Aguilera A, Domingo P, Galindo MJ, Miralles C, Del Pozo MA, Ribera E, Iribarren JA, Ruiz L, de la Torre J, Vidal F, Clotet B, Albert J, Heidarian A, Aperia-Peipke K, Axelsson M, Mild M, Karlsson A, Sönnerborg A, Thalme A, Navér L, Bratt G, Karlsson A, Blaxhult A, Gisslén M, Svennerholm B, Bergbrant I, Björkman P, Säll C, Mellgren Å, Lindholm A, Kuylenstierna N, Montelius R, Azimi F, Johansson B, Carlsson M, Johansson E, Ljungberg B, Ekvall H, Strand A, Mäkitalo S, Öberg S, Holmblad P, Höfer M, Holmberg H, Josefson P, Ryding U.

Clin Infect Dis. 2016 Mar 1;62(5):655-663. doi: 10.1093/cid/civ963. Epub 2015 Nov 29.

18.

Impact of Male Circumcision among heterosexual HIV cases: comparisons between three low HIV prevalence countries.

Chemtob D, Op de Coul E, van Sighem A, Mor Z, Cazein F, Semaille C.

Isr J Health Policy Res. 2015 Aug 4;4:36. doi: 10.1186/s13584-015-0033-8. eCollection 2015.

19.

Tuberculosis screening programmes for migrants to low-incidence countries--the Israeli experience.

Chemtob D, Mor Z, Grotto I.

Lancet Infect Dis. 2015 Aug;15(8):876. doi: 10.1016/S1473-3099(15)00138-3. Epub 2015 Jul 19. No abstract available.

PMID:
26227755
20.

Towards tuberculosis elimination: an action framework for low-incidence countries.

Lönnroth K, Migliori GB, Abubakar I, D'Ambrosio L, de Vries G, Diel R, Douglas P, Falzon D, Gaudreau MA, Goletti D, González Ochoa ER, LoBue P, Matteelli A, Njoo H, Solovic I, Story A, Tayeb T, van der Werf MJ, Weil D, Zellweger JP, Abdel Aziz M, Al Lawati MR, Aliberti S, Arrazola de Oñate W, Barreira D, Bhatia V, Blasi F, Bloom A, Bruchfeld J, Castelli F, Centis R, Chemtob D, Cirillo DM, Colorado A, Dadu A, Dahle UR, De Paoli L, Dias HM, Duarte R, Fattorini L, Gaga M, Getahun H, Glaziou P, Goguadze L, Del Granado M, Haas W, Järvinen A, Kwon GY, Mosca D, Nahid P, Nishikiori N, Noguer I, O'Donnell J, Pace-Asciak A, Pompa MG, Popescu GG, Robalo Cordeiro C, Rønning K, Ruhwald M, Sculier JP, Simunović A, Smith-Palmer A, Sotgiu G, Sulis G, Torres-Duque CA, Umeki K, Uplekar M, van Weezenbeek C, Vasankari T, Vitillo RJ, Voniatis C, Wanlin M, Raviglione MC.

Eur Respir J. 2015 Apr;45(4):928-52. doi: 10.1183/09031936.00214014. Review.

21.

Drug-resistant tuberculosis in Israel: risk factors and treatment outcomes.

Mor Z, Goldblatt D, Kaidar-Shwartz H, Cedar N, Rorman E, Chemtob D.

Int J Tuberc Lung Dis. 2014 Oct;18(10):1195-201. doi: 10.5588/ijtld.14.0192.

PMID:
25216833
22.

Molecular epidemiology and mapping of tuberculosis in Israel: do migrants transmit the disease to locals?

Goldblatt D, Rorman E, Chemtob D, Freidlin PJ, Cedar N, Kaidar-Shwartz H, Dveyrin Z, Mor Z.

Int J Tuberc Lung Dis. 2014 Sep;18(9):1085-91. doi: 10.5588/ijtld.14.0186.

PMID:
25189557
23.

Mortality of tuberculosis patients during treatment in Israel, 2000-2010.

Shuldiner J, Leventhal A, Chemtob D, Mor Z.

Int J Tuberc Lung Dis. 2014 Jul;18(7):818-23. doi: 10.5588/ijtld.13.0591.

PMID:
24902558
24.

Tuberculosis incidence in HIV/AIDS patients in Israel, 1983-2010.

Mor Z, Lidji M, Cedar N, Grotto I, Chemtob D.

PLoS One. 2013 Nov 21;8(11):e79691. doi: 10.1371/journal.pone.0079691. eCollection 2013.

25.

Thirty years of HIV in Israel: current epidemiology and future challenges.

Mor Z, Weinstein R, Grotto I, Levin Y, Chemtob D.

BMJ Open. 2013 Jul 6;3(7). pii: e003078. doi: 10.1136/bmjopen-2013-003078. Print 2013.

26.

What do we need to learn for policy decision-making on sexually transmitted infections prevention and treatment in Israel?

Chemtob D, Zenilman JM, Gandacu D.

Int J STD AIDS. 2012 Sep;23(9):e11-5. doi: 10.1258/ijsa.2009.009338.

PMID:
23033531
27.

High-risk behaviour in steady and in casual relationships among men who have sex with men in Israel.

Mor Z, Davidovich U, Bessudu-Manor N, McFarlane M, Feldshtein G, Chemtob D.

Sex Transm Infect. 2011 Oct;87(6):532-7. doi: 10.1136/sextrans-2011-050048.

PMID:
21917699
28.

A comparative examination of tuberculosis immigration medical screening programs from selected countries with high immigration and low tuberculosis incidence rates.

Alvarez GG, Gushulak B, Abu Rumman K, Altpeter E, Chemtob D, Douglas P, Erkens C, Helbling P, Hamilton I, Jones J, Matteelli A, Paty MC, Posey DL, Sagebiel D, Slump E, Tegnell A, Valín ER, Winje BA, Ellis E.

BMC Infect Dis. 2011 Jan 4;11:3. doi: 10.1186/1471-2334-11-3.

29.

Pediatric tuberculosis immigration screening in high-immigration, low-incidence countries.

Alvarez GG, Clark M, Altpeter E, Douglas P, Jones J, Paty MC, Posey DL, Chemtob D.

Int J Tuberc Lung Dis. 2010 Dec;14(12):1530-7. Erratum in: Int J Tuberc Lung Dis. 2011 Mar;15(3):425.

PMID:
21144237
30.

Tuberculosis contact investigation in low prevalence countries: a European consensus.

Erkens CG, Kamphorst M, Abubakar I, Bothamley GH, Chemtob D, Haas W, Migliori GB, Rieder HL, Zellweger JP, Lange C.

Eur Respir J. 2010 Oct;36(4):925-49. doi: 10.1183/09031936.00201609.

31.

Rationale and staff evaluation of using a "therapeutic milieu" for substance users within a tuberculosis ward.

Chemtob D, Levy A.

Subst Use Misuse. 2009;44(5):672-83. doi: 10.1080/10826080802494701.

PMID:
19266356
32.

Risk of tuberculosis in close contacts of patients with multidrug resistant tuberculosis: a nationwide cohort.

Attamna A, Chemtob D, Attamna S, Fraser A, Rorman E, Paul M, Leibovici L.

Thorax. 2009 Mar;64(3):271. doi: 10.1136/thx.2008.100974. No abstract available.

PMID:
19252032
33.

Gay men who engage in substance use and sexual risk behaviour: a dual-risk group with unique characteristics.

Mor Z, Davidovich U, McFarlane M, Feldshtein G, Chemtob D.

Int J STD AIDS. 2008 Oct;19(10):698-703. doi: 10.1258/ijsa.2008.008061.

PMID:
18824624
34.

["Injecting clean or being clean?" The international and Israeli experiences of Syringe Exchange Programs among injecting drug users].

Chemtob D, Levit S, Mell H, Margolis A, Levy A, Leventhal A.

Harefuah. 2008 Jul;147(7):634-8, 660. Review. Hebrew.

PMID:
18814525
35.

Mortality of hospitalized tuberculosis patients in Israel.

Chemtob D.

Isr Med Assoc J. 2008 Mar;10(3):245; author reply 245. No abstract available.

36.

Tuberculosis behind bars in Israel: policy making within a dynamic situation.

Mor Z, Adler A, Leventhal A, Volovic I, Rosenfeld E, Lobato MN, Chemtob D.

Isr Med Assoc J. 2008 Mar;10(3):202-6.

37.

[Aids and the right to privacy].

Mor Z, Chemtob D, Hildesheimer GM, Leventhal A.

Harefuah. 2007 Mar;146(3):200-5, 245-6. Review. Hebrew.

PMID:
17460928
38.

Sexually transmitted infections among individuals with and without HIV.

Chemtob D, Sasson M, Leventhal A, Stein-Zamir C, Maayan S.

Isr Med Assoc J. 2006 Dec;8(12):892. No abstract available.

39.

[Human immunodeficiency virus in newborn of infected mothers: pregnancy, breast feeding and prevention].

Mor Z, Chemtob D, Pessach N, Nitzan-Kaluski D.

Harefuah. 2006 Sep;145(9):682-6, 701. Review. Hebrew.

PMID:
17078432
40.

"Getting AIDS: not in my back yard." Results from a national knowledge, attitudes and practices survey.

Chemtob D, Damelin B, Bessudo-Manor N, Hassman R, Amikam Y, Zenilman JM, Tamir D.

Isr Med Assoc J. 2006 Sep;8(9):610-4.

41.
42.

Epidemiology of HIV infection among Israeli Arabs.

Chemtob D, Srour SF.

Public Health. 2005 Feb;119(2):138-43.

PMID:
15694960
43.

Epidemiology of adult and adolescent HIV infection in Israel: a country of immigration.

Chemtob D, Grossman Z.

Int J STD AIDS. 2004 Oct;15(10):691-6.

PMID:
15479507
44.

Compulsory detention of recalcitrant tuberculosis patients in the context of a new tuberculosis control programme in Israel.

Weiler-Ravell D, Leventhal A, Coker RJ, Chemtob D.

Public Health. 2004 Jul;118(5):323-8.

PMID:
15178138
45.

Circumstances leading to the formulation and implementation of a new TB control program in Israel: a case study in public health and policy.

Weiler-Ravell D, Leventhal A, Berlowitz Y, Rishpon S, Chemtob D.

J Public Health Policy. 2004;25(1):23-37.

PMID:
15134130
46.

Screening and management of tuberculosis in immigrants: the challenge beyond professional competence.

Chemtob D, Leventhal A, Weiler-Ravell D.

Int J Tuberc Lung Dis. 2003 Oct;7(10):959-66.

PMID:
14552566
47.

[Migrant workers: evolution of the Israel health system approach to the new social issue].

Leventhal A, Berlowitz Y, Chemtob D.

Harefuah. 2003 Sep;142(8-9):632-5, 644. Review. Hebrew.

PMID:
14518170
48.

The new National Tuberculosis Control Programme in Israel, a country of high immigration.

Chemtob D, Leventhal A, Berlowitz Y, Weiler-Ravell D.

Int J Tuberc Lung Dis. 2003 Sep;7(9):828-36.

PMID:
12971665
49.

[The new national program for tuberculosis elimination in Israel].

Chemtob D, Leventhal A, Berlowitz Y, Weiler-Ravell D.

Harefuah. 2002 Mar;141(3):265-71, 314. Review. Hebrew.

PMID:
11944221
50.

[Tuberculosis in Israel--main epidemiological aspects].

Chemtob D, Leventhal A, Weiler-Ravell D.

Harefuah. 2002 Mar;141(3):226-32, 316. Hebrew.

PMID:
11944211

Supplemental Content

Loading ...
Support Center